M.D., Ph.D., Department of Interventional Radiology, Zhongshan Hospital, Fudan University

● Research Focus: Clinical and mechanistic research on interventional therapy for liver tumors.

● Principal Investigator of 1 National Natural Science Foundation of China (NSFC) project; core participant in 1 NSFC General Program and 2 National Major Research Projects; co-authored 1 monograph; filed 10 invention patents.

● Executive Editor-in-Chief, TransMed.

● Recipient of the CCI 2025 Interventional New Pioneer Award, Chinese College of Interventionalists (CCI).

● Named to the "World's Top 2% Scientists" list in 2025.

● Published over 100 SCI papers in recent years; authored or co-authored over 60 papers as first/corresponding author in journals such as Science Advances, iMeta, Nature Communications, Molecular Cancer, Military Medical Research, APSB, Trends, etc., with a cumulative impact factor exceeding 700.

● Serves as Academic Advisor/Editorial Board Member for SCI journals including BMC Cancer, Journal of Immunology Research, and CEPP; Academic Editorial Board Member for Military Medical Research and Exploration; Guest Editor for over 10 journals including Mediators of Inflammation and Journal of Translational Internal Medicine.